Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12767900rdf:typepubmed:Citationlld:pubmed
pubmed-article:12767900lifeskim:mentionsumls-concept:C0699791lld:lifeskim
pubmed-article:12767900lifeskim:mentionsumls-concept:C1326205lld:lifeskim
pubmed-article:12767900lifeskim:mentionsumls-concept:C0021745lld:lifeskim
pubmed-article:12767900lifeskim:mentionsumls-concept:C1518174lld:lifeskim
pubmed-article:12767900lifeskim:mentionsumls-concept:C0521447lld:lifeskim
pubmed-article:12767900lifeskim:mentionsumls-concept:C0010592lld:lifeskim
pubmed-article:12767900lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:12767900lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:12767900lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:12767900pubmed:issue4lld:pubmed
pubmed-article:12767900pubmed:dateCreated2003-5-27lld:pubmed
pubmed-article:12767900pubmed:abstractTextWe previously reported synergistic induction of apoptosis by IFN-gamma plus either cyclosporin A (CsA) or tacrolimus (FK506) in gastric carcinoma cells. In this study, we aimed to elucidate the mechanism for this synergistic induction of apoptosis. IFN-gamma plus CsA synergistically induced caspase-3 mediated apoptosis in gastric carcinoma cells. Although IFN-gamma induced activation of signal transducer and activator of transcription1 (STAT1) and expression of interferon regulatory factor-1 (IRF-1) mRNA, IFN-gamma alone was not able to induce caspase-3 activation and apoptosis. When gastric carcinoma cells were treated with cyclohexamide, a protein synthesis inhibitor, following IFN-gamma pretreatment, caspase-3 was activated, and apoptosis was markedly induced. These findings suggest the existence of IFN-gamma-induced anti-apoptotic pathway and we evaluated the effect of IFN-gamma and CsA on calcium-sensitive nuclear factor-kappa B (NF-kappa B) activation. IFN-gamma increased intracellular calcium ion concentration ([Ca(2+)](i)) consisting of a spike and a sustained phase, and the latter was completely abrogated by CsA. Activation of NF-kappa B occurred in response to IFN-gamma, and which was markedly inhibited by either CsA or FK506. NF-kappa B decoy also enhanced the cytotoxic effect of IFN-gamma. These results suggest that IFN-gamma may simultaneously induce the STAT1-mediated apoptotic pathway and the anti-apoptotic pathway through calcium-activated NF-kappa B and that inhibition of the latter by CsA may result in dominance of the apoptosis-inducing pathway.lld:pubmed
pubmed-article:12767900pubmed:languageenglld:pubmed
pubmed-article:12767900pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767900pubmed:citationSubsetIMlld:pubmed
pubmed-article:12767900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767900pubmed:statusMEDLINElld:pubmed
pubmed-article:12767900pubmed:monthJunlld:pubmed
pubmed-article:12767900pubmed:issn0006-291Xlld:pubmed
pubmed-article:12767900pubmed:authorpubmed-author:TanakaMasaoMlld:pubmed
pubmed-article:12767900pubmed:authorpubmed-author:IharaEikichiElld:pubmed
pubmed-article:12767900pubmed:authorpubmed-author:KatanoMitsuoMlld:pubmed
pubmed-article:12767900pubmed:authorpubmed-author:MorisakiTakas...lld:pubmed
pubmed-article:12767900pubmed:authorpubmed-author:UchiyamaAkihi...lld:pubmed
pubmed-article:12767900pubmed:authorpubmed-author:KanaideHideoHlld:pubmed
pubmed-article:12767900pubmed:authorpubmed-author:HiranoKatsuya...lld:pubmed
pubmed-article:12767900pubmed:authorpubmed-author:MatsunagaHisa...lld:pubmed
pubmed-article:12767900pubmed:authorpubmed-author:BeppuKiichiro...lld:pubmed
pubmed-article:12767900pubmed:issnTypePrintlld:pubmed
pubmed-article:12767900pubmed:day13lld:pubmed
pubmed-article:12767900pubmed:volume305lld:pubmed
pubmed-article:12767900pubmed:ownerNLMlld:pubmed
pubmed-article:12767900pubmed:authorsCompleteYlld:pubmed
pubmed-article:12767900pubmed:pagination797-805lld:pubmed
pubmed-article:12767900pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:meshHeadingpubmed-meshheading:12767900...lld:pubmed
pubmed-article:12767900pubmed:year2003lld:pubmed
pubmed-article:12767900pubmed:articleTitleInhibition of interferon-gamma-activated nuclear factor-kappa B by cyclosporin A: A possible mechanism for synergistic induction of apoptosis by interferon-gamma and cyclosporin A in gastric carcinoma cells.lld:pubmed
pubmed-article:12767900pubmed:affiliationDepartment of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyusyu University, Fukuoka 812-8582, Japan.lld:pubmed
pubmed-article:12767900pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12767900lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12767900lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12767900lld:pubmed